Testing effectiveness (Phase 2)Study completedNCT00697567
What this trial is testing
Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant
Who this might be right for
Prophylaxis Herpes Simplex
GlaxoSmithKline 80